MedTrace Logo

The Pharmacokinetics and Potential Health Effects of Champagne Wine in Human Subjects

NCT00937313 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2009-07-13

No results posted yet for this study

Summary

* To assess whether acute, moderate Champagne wine consumption modulates endothelial function in healthy human volunteers.
* To establish the bioavailability of Champagne wine polyphenols and their metabolism.

Conditions

  • No Condition. Assessment of Healthy Volunteers.

Interventions

OTHER

Champagne wine intervention

Placebo-controlled randomised cross-over human trial

Sponsors & Collaborators

  • University of Reading

    lead OTHER

Principal Investigators

  • Jeremy PE Spencer, PhD · The University of Reading

  • David Vauzour, PhD · The University of Reading

  • Julie Lovegrove, PhD · The University of Reading

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-02-29
Completion
2008-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00937313 on ClinicalTrials.gov